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DOI 10.1016/j.stem.2008.10.002Human fibroblasts can be induced into
pluripotent stem cells (iPSCs), but the re-
programming efficiency is quite low. Here,
we screened a panel of candidate factors
in the presence of OCT4, SOX2, KLF4,
and c-MYC in an effort to improve the re-
programming efficiency from human adult
fibroblasts. We found that p53 siRNA and
UTF1 enhanced the efficiency of iPSC
generation up to 100-fold, even when the
oncogene c-MYC was removed from the
combinations.
We initially screened a panel of candi-
date factors, including NANOG, LIN28,
DPPA4, DPPA5, ZIC3, BCL-2, h-RAS,
TPT1, SALL2, NAC1, DAX1, TERT,
ZNF206, FOXD3, REX1, UTF1, and p53-
siRNA, which might facilitate the repro-
gramming process. In our experiment,
when OCT4, SOX2, KLF4, and c-MYC
were introduced into fibroblasts from the
foreskin of an adult (hAFF), cell clusters
started to emerge at day 10 posttrans-
duction. When analyzed by AP staining
at day 18 posttransduction, the colonies
were divisible into three groups: AP-nega-
tive granulated colonies, AP-low/non-
compact colonies, and highly AP-positive
compact colonies (see Figure S2A avail-
able online). Subsequently, the additional
candidate factors were separately intro-
duced into fibroblasts together with the
four reprogramming factors (referred to
as the 4+1 strategy). All but two of the
tested factors did not noticeably increase
the efficiency of AP-positive colony for-
mation. However, 18 days posttransduc-
tion, cells that had been introduced with
4+p53 siRNA and 4+UTF1 exhibited an
increased efficiency in the yield of highly
AP-positive colonies (Figure 1A), while
a nonsense siRNA used as a control forthe p53 siRNA had no effect (data not
shown). Strikingly, when these six factors
(4+p53 siRNA+UTF1) were used together,
the efficiency of highly AP-positive colony
generation was elevated by more than
200 times compared with just using the
four factors (Figure 1A). Moreover, when
the six factors were introduced into differ-
ent kinds of target cells, including neona-
tal fibroblasts (BJ fibroblasts), human
embryonic fibroblasts (hEF), and fetal
skin fibroblasts (hFSF), highly AP-positive
colonies were also generated at a compa-
rably high efficiency (data not shown).
Because AP activity was only an early
event in mouse iPSC generation, we fur-
ther investigated whether p53 siRNA and
UTF1 could enhance the efficiency of
generating final-stage iPSCs from human
adult fibroblasts. We found that before
day 18 posttransduction, the highly AP-
positive colonies were mostly GFP posi-
tive (GFPwasdriven by theCMVpromoter
in the lentiviral vector pLL3.7 and was
used as an indicator of exogenous trans-
gene expression; Figures 1Bh and S1B).
Several GFP-positive colonies were
chosen for further analyses, and they
were found to maintain AP activity and
GFP expression for at least 20 passages
but display an extremely low efficiency of
spontaneous and directed differentiation
in vitro (data not shown). None of them
could form teratoma in vivo. These results
suggest that the GFP-positive cells might
be partially reprogrammed cells (referred
to as pre-iPSCs). RT-PCR and microarray
data further confirmed that these cells
were trapped in an intermediate state
(Figures 2A and 2C).
After day 18 posttransduction, GFP-
silenced colonies began to emerge (Fig-Cell Stem Cell 3ures 1Bd and S2B), which more closely
resembled human embryonic stem cell
(hESC) colonies in morphology, with
clear-cut round edges, high nucleus/cyto-
plasm ratio, homogeneity, and a tendency
to form monolayers (Figures 1B and S2B).
Based on previous published studies
suggesting that exogenous gene silenc-
ing might distinguish a pluripotency state
(Hotta and Ellis, 2008), we calculated the
number of iPSC colonies by using exoge-
nous GFP silencing and morphology
resembling hESCs as the criteria. On
day 25 posttransduction, we found that
4+p53 siRNA and 4+UTF1 significantly
increased the efficiency of iPSC genera-
tion (Figure 1Cc). Moreover, when the six
factors were used, the number of gener-
ated iPSC colonies was elevated up to
100 times, compared with just using the
four factors (Figure 1Cc). Interestingly,
we found that p53 siRNA dramatically
enhanced the total numbers of cell colo-
nies, but it did not further exert its effect
on the highly AP-positive colony numbers
or iPSC numbers (Figure 1C). Meanwhile,
UTF1 had little effect on the total colony
numbers, but it significantly increased the
highly AP-positive colony numbers and
iPSC colony numbers (Figure 1C). This
suggests that p53 siRNA and UTF1 have
effects at different stages and can syner-
gize to support iPSC generation. A similar
effect was also achieved when other
fibroblasts were used, including BJ,
hFSF, and hEF (Figure S2C). To confirm
the iPSC generation efficiency estimated
by using exogenous GFP silencing and
morphology resembling hESCs as the cri-
teria, we performed immunostaining in the
primary culture dish for the endogenous
expression of NANOG and TRA-1-81,, November 6, 2008 ª2008 Elsevier Inc. 475
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(A) Increased efficiency of the of AP-positive colony generation by UTF1 (U) and p53 siRNA (P) in a repre-
sentative experiment. Cells (53 104) were plated onto a 10 cm dish. Shown are numbers of total colonies
and AP-highly positive colonies (in parenthesis) counted on day 18 posttransduction. ‘‘4’’ indicates the
reported four reprogramming factors OCT4 (O), SOX2 (S), KLF4 (K), and c-MYC (M).
(B) Typical colonies of human iPSCs (top panel) and incompletely reprogrammed highly AP-positive cells
(bottom panel). (Ba and Be) phase image; (Bb and Bf) high magnification; (Bc and Bg) AP staining; (Bd and
Bh) GFP fluorescence. Scale bars, 100 mm.
(C–E) Total colony numbers (left panels), highly AP-positive colony numbers (middle panels), and iPSC
colony numbers (right panels). The colony numbers shown are those induced from 105 cells plated on
the feeder cells by different combinations of factors. The results of three independent experiments
are shown with different colors. (C) Enhanced efficiency in the presence of the reported four reprogram-
ming factors. Numbers were counted on day 25 posttransduction. (D) The six-factor (4PU) combination
minus the reported four reprogramming factors, respectively. (Da and Db) Numbers were counted on
day 25 posttransduction. (Dc) Numbers were counted on day 35 posttransduction. (E) p53 siRNA and
UTF1 enhanced efficiency in the combinations without c-MYC. Numbers were counted on day 35
posttransduction.476 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.which was considered as a characteristic
of iPSCs (Brambrink et al., 2008; Stadtfeld
et al., 2008). We found that all the colonies
identified by the GFP-/ES-like criterion
were positive for NANOG and TRA-1-81
(Figure S3). The number of colonies
counted by the GFP-/ES-like criterion
was very similar to that judged by the
expression of NANOG and TRA-1-81 (Fig-
ure S3). Moreover, all of the colonies cho-
sen based on our criteria were further
validated to be iPSCs (Table S1). Taken
together, the results indicated that p53
siRNA andUTF1were able to dramatically
increase the efficiency of not only gener-
ating highly AP-positive colonies, but also
generating fully reprogrammed iPSCs by
up to 100 folds.
We also determinedwhether p53 siRNA
andUTF1 could substitute for the function
of the reported four reprogramming fac-
tors, by withdrawing each one of them
individually and using the remaining five
factors to induce iPSCs from hAFF cells
(6-1 strategy). We found that when OCT4,
SOX2, or KLF4 was separately removed
from the six factors (6-OCT4, 6-SOX2,
and 6-KLF4), although highly AP-positive
colonies were obtained (Figure 1Db), no
iPSC colonies were found, even extend-
ing the culture period to 60 days post-
transduction. These results suggest the
essential role of OCT4, SOX2, or KLF4 to
fulfill the iPSC induction process. When
c-MYC was removed (6-MYC), the total
colony number and highly AP-positive
colony number decreased dramatically
(Figures 1Da and 1Db). However, during
further cultivation, cell colonies continu-
ously emerged and subsequently devel-
oped into iPSC colonies. On day 35
posttransduction, 71 to 223 iPSC colonies
could be generated from 1 3 105 target
cells by 6-MYC, which was comparable
to that by the six factors (Figure 1Dc).
Interestingly, when c-MYC was removed
(6-MYC), the colonies emerging in further
cultivation were mostly iPSC colonies.
These results suggest that although
c-MYC benefits cell colony origination, it
is not indispensable in the iPSC genera-
tion process, especially in the presence
of p53 siRNA and UTF1.
Previous reports (Nakagawa et al.,
2008; Wernig et al., 2008) and our data
(Figure 1E) demonstrated that, when
c-MYC was withdrawn from the reported
four reprogramming factors, the effi-
ciency of generating human iPSC was
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(A) Semiquantitative RT-PCR analysis of hESC markers in iPSCs and pre-iPSCs.
(B) Immunocytochemical staining for hESC markers NANOG, SSEA-1, SSEA-4, TRA-1-60, and TRA-1-81
(red) in hAFF-4U-M-iPS-3. Nuclei are stained with DAPI (blue). Scale bars, 100 mm.
(C) Immunocytochemical staining for three germ layer markers in the differentiated human iPSCs. Ecto-
derm: PAX6 and NEUROFILAMENT (hAFF-4PU-iPS-13); GFAP and b-III-TUBULIN (hAFF-4U-M-iPS-3).
Mesoderm: a-SMA (hAFF-4PU-iPS-13); BRACHYURY and VIMENTIN (hAFF-4U-M-iPS-3). Endoderm:
SOX17 and FOXA2 (hAFF-4PU-iPS-13); CK18, ALB, and AFP (hAFF-4U-M-iPS-3). Scale bars, 25 mm
(ALBUMIN, BRACHYURY), 100 mm (others).
(D) DNA microarray and hierarchical clustering of global gene expression of human iPSCs, pre-iPSCs,
hESCs (H1, H7), and somatic cells (hAFF, hFSF).
(E) Teratoma formation of iPSCs. Nine-week teratomas were recovered from the SCID beige mouse. Cell
types of the three germ layers were found. (Ea–Eh) Teratoma derived from hAFF-4PU-iPS-13; (Ei–Ep) ter-
atoma derived from hAFF-4U-M-iPS-3. Ectoderm: nerve fiber (Ea) (NEUROFILAMENT positive), (Ej) and
(Em) (bottom left); neural tube-like epithelium, (Ec) (b-TUBULIN III positive), (Ek) and (Em) (upper right);
neuron-like cells, (Eb) (b-TUBULIN III positive); pigmented retinal epithelium, (Ed) and (Ei). Mesoderm:
smooth muscle, (Ee) (a-SMA positive), (Ef) (a-SMA positive), (El) and (Em) (middle); cartilage, (Eg) (VIMEN-
TIN positive), (Eo); bone, (Ep). Endoderm: gut-like epithelium, (Eh) (CK19 positive), (En). Scale bars, 50 mm.Cell Stem Cell 3,extremely low and not reproducible.
Notably, our data showed that when p53
siRNA and UTF1 were added together to
the combination of 4-MYC (OCT4, SOX2,
and KLF4), the efficiency of iPSC genera-
tion increased more than 100 folds
(Figure 1Ec). We further studied whether
p53 siRNA or UTF1 alone had a similar
effect. We found that, compared with
4-MYC, the addition of p53 siRNA (4-
MYC+p53 siRNA) orUTF1 (4-MYC+UTF1)
dramatically increased the efficiency of
iPSC generation (Figure 1Ec). In particu-
lar, when the combination of OCT4,
SOX2, KLF4, and UTF1 was used (4-
MYC+UTF1), iPSCs were induced at
efficiency of approximately 3 3 104,
which was at least ten times higher than
4-MYC (Figure 1Ec) and could be suc-
cessfully obtained every time. Therefore,
by replacing c-MYC with UTF1 from the
reported four reprogramming factors, we
have identified a novel combination of
four reprogramming factors to generate
iPSCs (OCT4, SOX2, KLF4, and UTF1),
which is more efficient, more reproduc-
ible, and not required for the oncogene
c-MYC. In addition, the ratio of iPSC colo-
nies to total colonies was much higher
when the new combination of four factors
was used (Figures 1C and 1E), which
made a more specific induction from
fibroblasts to iPSCs.
We established a panel of human iPSC
lines from fibroblasts using different
combinations of reprogramming factors.
These cell lines were further characterized
for pluripotency, gene expression profile,
differentiation potential, and genomic
stability (Table S1). The representative
data are shown in Figures 2 and S1–S7.
RT-PCR analysis indicated that the
endogenous pluripotency marker genes
were expressed at levels similar to those
of hESCs (Figure 2A), and the expression
of exogenous genes in most of the iPSC
lines have been silenced (Figure S4). The
expression of SSEA4, TRA1-60, TRA1-
81, and NANOG could be detected by im-
munostaining (Figure 2B). Microarray data
also uncovered a similar gene expression
profile pattern between iPSCs and hESCs
(Figure 2C). Bisulfite sequencing further
revealed that OCT4 and NANOG pro-
moters were demethylated in iPSCs,
which was similar to hESCs (Figure S5).
The human iPSC lines further analyzed in
our work were stable in culture and chro-
mosomal G-band analysis showed thatNovember 6, 2008 ª2008 Elsevier Inc. 477
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(Figure S6 and Table S1). STR analysis
showed that these cells were derived
from parental fibroblasts, not by contam-
ination from existing hESCs in our labora-
tory (Table S2).
In order to analyze the differentiation
potential of iPSC lines, we tested their
capacity for spontaneous and direct dif-
ferentiation into the cell types of the three
germ layers. After 8 days of floating culti-
vation, embryoid bodies (EB) were formed
(Figure S7A). After attachment, immuno-
cytochemical staining showed that the
differentiated cells were positive for
NEUROFILAMENT, a-SMA, VIMENTIN,
and ALBUMIN (Figure 2D). RT-PCR anal-
ysis also confirmed differentiation into
three germ layers (Figure S7B). iPSCs
were also induced to differentiate directly
into neural cells, and the differentiated
cells expressed the neural markers PAX6,
B-III-TUBULIN, and GFAP (Figure 2D).
Directed differentiation to hematopoietic
lineage cells resulted in BRACHYURY
expression (Figure 2D) and subsequent
GATA2, CD31, and KDR expression (Fig-
ure S7C) (Zhang et al., 2008). Directed
differentiation to endoderm cell lineages
was also performed as reported previ-
ously (Cai et al., 2007; Jiang et al., 2007).
The differentiated human iPSCs were
positive for CK18, SOX17, FOXA2, and
AFP (Figure 2D). When induced with
BMP4 for 9 days, the human iPSCs
exhibited differentiation potential toward
trophoblasts (Figure S7D). Moreover, five
iPSC lines were chosen for teratoma
test, and all of them were found to form
teratomas in vivo 6–9 weeks after injec-
tion (Table S1). In these teratomas, tis-
sues of all three germ layers were found
(Figure 2E). In conclusion, the iPSCs gen-
erated in this work have a similar gene
expression profile and differentiation
potential as hESCs.
In summary, we have identified two
factors, p53 siRNA and UTF1, that can in-
crease the efficiency of human iPSC gen-
eration by up to 100 times in the presence
of four reprogramming factors. It has been
reported that KLF4, an important repro-
gramming factor, likely functions by p53
suppression (Rowland et al., 2005). How-
ever, we found that p53 knockdown could
not completely substitute for the function
of KLF4 in the reprogramming process.
Although a large amount of AP-positive
colonies could be obtained, no iPSCs478 Cell Stem Cell 3, November 6, 2008 ª2could be generated by introduction of
p53 siRNA instead of KLF4 (data not
shown). Therefore, the suppression of
p53 expression might only be one of sev-
eral functions of KLF4. Loss of p53 may
play several roles in facilitating the repro-
gramming process to form iPSCs. First,
silencing p53 expression could promote
the immortalization of fibroblasts. When
fibroblasts are induced to become iPSCs,
they not only become pluripotent, but also
become immortal. Immortalization of
fibroblasts requires the cells to overcome
the cellular senescence process, which
can be effected by p53 siRNA. Our re-
sults, together with other related reports
(Mali et al., 2008; Qin et al., 2007; Zhao
and Daley, 2008), suggest that cellular
senescence may act as a barrier for the
generation of iPSCs. p53 siRNA may also
function as an antagonist of cellular apo-
ptosis and consequently contribute to the
reprogramming process. Yamanaka has
suggested that c-MYC may induce se-
nescence and apoptosis during the gen-
eration of iPSCs by activating the p53
pathway, and our data are consistent
with this possibility (Yamanaka, 2007).
We found that the introduction of c-MYC
in human fibroblasts causes significant
apoptosis and loss of cells, which can be
significantly suppressed when p53 siRNA
was introduced together with c-MYC
(data not shown).
We also found that expression of UTF1
significantly increases the efficiency of
iPSC generation. It has been reported
that UTF1 possesses histone-like proper-
ties and is able to function as a stable
chromatin-associated transcriptional re-
pressor (van den Boom et al., 2007).
Thus, it is possible that UTF1 may favor
the switch of pluripotent from more differ-
entiated states, through the establish-
ment of an epigenetic profile or a specific
chromatin state susceptible to appropri-
ate cell fate stimuli. On the other hand,
UTF1 is also reported to be a downstream
factor of the OCT4/SOX2 complex, highly
expressed in ESCs and downregulated
at the onset of differentiation (Nishimoto
et al., 1999). Based on our finding re-
ported here that expression of UTF1 facil-
itates the formation of AP-positive and
iPSC colonies, we suggest that OCT4
and SOX2 may act through UTF1 in the
iPSC reprogramming process. However,
although UTF1 plays a critical role in the
OCT4 pathway, our studies also revealed008 Elsevier Inc.that expression of UTF1 alone is not suffi-
cient. We have tried to use UTF1 to re-
place OCT4 (USMK) among the reported
four reprogramming factors (OSMK).
Although similar number of AP-positive
colonies were generated compared to
OSMK, no iPSCs were obtained. There-
fore, there should be additional crucial
downstream effectors of OCT4 and SOX2
in the reprogramming process. Identifica-
tion of these downstream effectors should
provide a considerably bettermechanistic
understanding of reprogramming.
We developed a novel combination of
four factors to generate iPSCs. By using
UTF1 along with OCT4, SOX2, and KLF4,
iPSCs were generated more efficiently
fromhumanadult fibroblasts. In the future,
this is expected to facilitate the establish-
ment of patient-specific and disease-spe-
cific human iPSCs in the absence of the
oncogene c-MYC.
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